Genetic mutations, notably in the BRCA1 and BRCA2 genes but also in TP53, KRAS and PIK3CA, are central to understand this type of tumor since they highlight broader tumorigenic processes across OC [23, 24]. The gene discussed is BRCA1; the disease is neoplasm.